Bristol Myers Squibb (BMY) Leases (2019 - 2026)

Bristol Myers Squibb (BMY) has 8 years of Leases data on file, last reported at $1.5 billion in Q1 2026.

• Quarterly Leases rose 25.76% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 25.76% YoY) and the FY2025 annual result came in at $1.6 billion, up 29.25% from the prior year.
• Leases fell to $1.5 billion in Q1 2026 per BMY's latest filing, from $1.6 billion in the prior quarter.
• Across five years, Leases topped out at $1.6 billion in Q3 2025 and bottomed at $840.0 million in Q2 2022.
• The 5-year median for Leases is $1.3 billion (2024), against an average of $1.3 billion.
• The widest annual swing landed in 2022, when Leases dropped 16.5%; it then jumped 54.81% in 2023.
• Tracing BMY's Leases over 5 years: stood at $1.2 billion in 2022, then gained by 13.93% to $1.4 billion in 2023, then fell by 11.94% to $1.2 billion in 2024, then increased by 29.25% to $1.6 billion in 2025, then decreased by 3.41% to $1.5 billion in 2026.
• Per Business Quant, the three latest BMY Leases figures stand at $1.5 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025).

Peer Comparison